Press release
Postmenopausal Osteoporosis Market Share, Trends, Size, Research and Forecast 2018-2023
The postmenopausal osteoporosis market is expected to grow significantly during the forecast period (2018-2023). Osteoporosis is a skeletal disorder characterized by skeletal fragility, microarchitectural disruption, and low bone mass. It is a condition where the bone density and bone mass decreases and in the long run increases the risk of bone fracture. The global postmenopausal osteoporosis market is significantly growing due to some factors which include increasing geriatric population. Age is the major factor for the cause of the osteoporosis disease, hence rising geriatric population contributes in the market growth. Factors such as growing prevalence of osteoporosis and developing healthcare infrastructure across the globe also drive the growth of the segment.A full report of Postmenopausal Osteoporosis Market is available at: https://www.omrglobal.com/industry-reports/postmenopausal-osteoporosis-market
Changing lifestyle of people due to consumption of alcohol and smoking, mounting awareness among people through awareness initiatives and programs and continuous innovations in the drugs with the approval by the FDA creates the future opportunity for the growth of the market. On the other hand, there are various factors acting as the barriers for the market which includes the requirement of high standards for the approval of new product launch and increasing competition from the generics.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/postmenopausal-osteoporosis-market
Global postmenopausal osteoporosis market can be segmented on the basis of treatment and distribution channel. Based on the treatment, the market can be further diversified as bisphosphonates, hormones, strontium ranelate, raloxifene and denosumab. Among the treatment, bisphosphonates segment is expected to lead the market as it is extensively used for the prevention and treatment of postmenopausal osteoporosis. Furthermore, on the basis of distribution channel, the market can be bifurcated as hospital pharmacies, retail pharmacies and E-commerce pharmacies.
Considering the geographical regions, the global Postmenopausal Osteoporosis market is divided into North America, Europe, Asia Pacific, and Rest of the world. The largest market share is covered by North America due to growing geriatric population, high level of developed technologies and healthcare spending. Europe is the region which covers significant market share due to increase in research and development and new product innovations. Asia Pacific considered as the fastest growing economy with the rising awareness among people, developing technologies and healthcare infrastructure.
The companies contributing to the global market includes Eli Lilly and company, Pfizer Inc., Proctor & Gamble Co., Amgen Inc., Novartis International AG, Allergan plc, Deltanoid Pharmaceuticals Inc., Novo- Nordisk A/S, and Phytohealth Corporation. The companies are entering into mergers and partnership in order to introduced new product innovation which in return enhance the market growth. For an instance: Radius Health, Inc. in April 2017, received FDA approval for TYMLOS (abaloparatide) injection to treat postmenopausal women with osteoporosis. TYMLOS in postmenopausal women with osteoporosis, reduce the risk of vertebral and nonvertebral fractures.
Postmenopausal Osteoporosis Market- Segmentation
By Treatment
• Bisphosphonates
• Hormones
• Strontium Ranelate
• Raloxifene
• Denosumab
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• E- Commerce Pharmacies
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/postmenopausal-osteoporosis-market
Postmenopausal Osteoporosis Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Allergan Plc
• Amgen Inc.
• BiologicsMD, Inc.
• Deltanoid Pharmaceuticals Inc
• Eli Lilly and Company
• Enteris BioPharma, Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc.
• Ligand Pharmaceuticals Inc.
• Merck & Co., Inc.
• Novartis International AG
• Noven Pharmaceuticals, Inc.
• Novo Nordisk A/S
• Oncobiologics Inc.
• Paras Biopharmaceuticals Finland Oy
• Pfizer Inc.
• PhytoHealth Corp.
• Procter & Gamble CO.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postmenopausal Osteoporosis Market Share, Trends, Size, Research and Forecast 2018-2023 here
News-ID: 2221226 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
